Adjuvant chemoradiation offers minimal survival improvements over radiation alone in intermediate‐risk, early cervical cancer

This news section offers Cancer readers timely information on events, public policy analysis, and topical issues. In this issue, adjuvant chemoradiation offers minimal survival improvements over radiation alone in intermediate‐risk, early‐stage cervical cancer, according to trial results. In addition, aspirin use reduced recurrence in a molecularly defined subgroup of patients with colorectal cancer, and patients with metastatic breast cancer or metastatic non–small cell lung cancer with leptomeningeal metastatic disease who underwent proton craniospinal irradiation had improved central nervous system progression‐free survival.